Miriam Bortnik

Implantable Cardioverter Defibrillators and Cellular Telephones: Is There Any Interference?

The aim of our study was to consider cellular telephone interference using different cellular telephones and implantable cardioverter defibrillator (ICD) models. Thirty (26 men, 4 women) patients with ICDs were considered during follow‐up. The ICD models were: Telectronics (7), CPI (7), Medtronic (7), Ventritex (5), and Ela Medical (4). All patients were monitored with surface ECG; permanent telemetric endo‐ECG monitoring was activated. Then, the effect of two different European telephone systems were tested: TACS system (Sony CM‐R111, 2 W power) and GSM system (Motorola MG1–4A11, 2 W power). For both systems, the effect during call, reception, active conversation (dialogue), and passive conversation (listening) were observed. Cellular telephones were located first in contact with the programming head, then near the leads system, and lastly, in the hands of the patient. At the end of the evaluations, memories were interrogated again to check for false arrhythmia detections. In five of these patients during arrhythmia induction at device implant (first implant or ICD replacement), we also evaluated possible interference between cellular telephones in the reception phase and the ventricular fibrillation detection phase of the ICD. All evaluated models showed significant noise in the telemetric transmission when the cellular telephone (both TACS and GSM) was located near the ICD and the programming head; noise was particularly significant during call and reception, in most cases leading to loss of telemetry. No false arrhythmia detections have been observed during tests with cellular telephones located on the ICDs. During tests performed with cellular telephones located near the leads or in the hands of patients, no telemetric noises or false arrhythmia detections were observed. During induced ventricular fibrillation and cellular telephones in reception mode near the device, the arrhythmia recognition was always correct and not delayed. In conclusion, present ICD models seem to be well protected from electromagnetic interference caused by European cellular telephones (TACS and GSM), without under‐/oversensing of ventricular arrhythmias. However, cellular telephones disturb telemetry when located near the programming head. ICD patients should not be advised against the use of cellular telephones, but it has to be avoided during ICD interrogation and programming.

Orthostatic hypotension as an unusual clinical manifestation of pheochromocytoma: a case report.

Pheochromocytoma is a rare endocrine tumor which can have a highly variable presentation related to increased catecholamine secretion. We report the case of a 74-year-old man in whom recurrent episodes of syncope due to orthostatic hypotension were the only clinical manifestations of this challenging entity. Diagnosis of pheochromocytoma was achieved by biochemical test samples and computed tomography scans. Surgical excision of the tumor resulted in clinical improvement with normalization of catecholamine concentrations and no more episodes of orthostatic hypotension during a follow-up of 24 months. Although rare, pheochromocytoma may frequently cause disorders of orthostatic tolerance; because of its meaningful implications, screening for this entity should be considered in case of recurrent syncopal episodes due to new-onset orthostatic hypotension.

Long-term follow-up of DDDR closed-loop cardiac pacing for the prevention of recurrent vasovagal syncope.

Aims Vasovagal syncope (VVS) is a common disorder characterized by a drop in blood pressure accompanied with bradycardia; although it is generally considered a benign condition, some patients may be highly symptomatic despite general counselling and/or pharmacological therapy. Closed-loop stimulation (CLS), responding to myocardial contraction dynamics, demonstrated effectiveness in short-term prevention of recurrent VVS. The aim of this study was to evaluate CLS pacing in a long-term follow-up. Methods The study involved 35 patients (mean age 59 ± 15 years) with 3 years’ follow-up (mean 61 ± 35 months). We compared syncopal events and presyncopes before and after CLS implantation. Mean number of syncopes for patients was six (range 1–24; 212 syncopal spells registered) before pacemaker implantation. Results At follow-up, 29 of 35 patients (83%) were asymptomatic; one patient experienced recurrent loss of consciousness but reported an improvement in the quality of life (one syncope or presyncope per month after CLS, vs. one syncope per week and daily presyncopes before CLS). Five patients experienced syncopal recurrences after CLS (range: 1–7, with a total of 15 episodes); in all the cases, the number of post-CLS syncopes was significantly lower. Conclusion Our study seems to confirm previous results of short-term trials: DDDR-CLS pacing is an extremely useful tool in the prevention of recurring VVS, even in long-term follow-up.

Usefulness of Hemodynamic Sensors for Physiologic Cardiac Pacing in Heart Failure Patients

The rate adaptive sensors applied to cardiac pacing should respond as promptly as the normal sinus node with an highly specific and sensitive detection of the need of increasing heart rate. Sensors operating alone may not provide optimal heart responsiveness: central venous pH sensing, variations in the oxygen content of mixed venous blood, QT interval, breathing rate and pulmonary minute ventilation monitored by thoracic impedance variations, activity sensors. Using sensors that have different attributes but that work in a complementary manners offers distinct advantages. However, complicated sensors interactions may occur. Hemodynamic sensors detect changes in the hemodynamic performances of the heart, which partially depends on the autonomic nervous system-induced inotropic regulation of myocardial fibers. Specific hemodynamic sensors have been designed to measure different expression of the cardiac contraction strength: Peak Endocardial Acceleration (PEA), Closed Loop Stimulation (CLS) and TransValvular Impedance (TVI), guided by intraventricular impedance variations. Rate-responsive pacing is just one of the potential applications of hemodynamic sensors in implantable pacemakers. Other issues discussed in the paper include: hemodynamic monitoring for the optimal programmation and follow up of patients with cardiac resynchronization therapy; hemodynamic deterioration impact of tachyarrhythmias; hemodynamic upper rate limit control; monitoring and prevention of vasovagal malignant syncopes.

Effects of closed-loop stimulation vs. DDD pacing on haemodynamic variations and occurrence of syncope induced by head-up tilt test in older patients with refractory cardioinhibitory vasovagal syncope: the Tilt test-Induced REsponse in Closed-loop Stimulation multicentre, prospective, single blind, randomized study

Aims Closed-loop stimulation (CLS) seemed promising in preventing the recurrence of vasovagal syncope (VVS) in patients with a cardioinhibitory response to head-up tilt test (HUTT) compared with conventional pacing. We hypothesized that the better results of this algorithm are due to its quick reaction in high-rate pacing delivered in the early phase of vasovagal reflex, which increase the cardiac output and the blood pressure preventing loss of consciousness. Methods and results This prospective, randomized, single-blind, multicentre study was designed as an intra-patient comparison and enrolled 30 patients (age 62.2 ± 13.5 years, males 60.0%) with cardioinhibitory VVS, carrying a dual-chamber pacemaker incorporating CLS algorithm. Two HUTTs were performed one week apart: one during DDD-CLS 60-130/min pacing and the other during DDD 60/min pacing; patients were randomly and blindly assigned to two groups: in one the first HUTT was performed in DDD-CLS (n = 15), in the other in DDD (n = 15). Occurrence of syncope and haemodynamic variations induced by HUTT was recorded during the tests. Compared with DDD, DDD-CLS significantly reduced the occurrence of syncope induced by HUTT (30.0% vs. 76.7%; P < 0.001). In the patients who had syncope in both DDD and DDD-CLS mode, DDD-CLS significantly delayed the onset of syncope during HUTT (from 20.8 ± 3.9 to 24.8 ± 0.9 min; P = 0.032). The maximum fall in systolic blood pressure recorded during HUTT was significantly lower in DDD-CLS compared with DDD (43.2 ± 30.3 vs. 65.1 ± 25.8 mmHg; P = 0.004). Conclusion In patients with cardioinhibitory VVS, CLS reduces the occurrence of syncope induced by HUTT, compared with DDD pacing. When CLS is not able to abort the vasovagal reflex, it seems to delay the onset of syncope.

Do electrical parameters of the cardiac cycle reflect the corresponding mechanical intervals as the heart rate changes

AIMS The evoked QT interval can be detected beat by beat through an implanted pacing system. The correlation between the right ventricular paced QT interval and the left ventricular systolic interval is not known. The aim of our study was to collect data on the correlation between QT and systolic and diastolic indexes at different heart rates in patients with dual-chamber rate-responsive pacemakers. METHOD AND RESULTS The study involved 13 patients [67 +/- 9 years; ejection fraction (EF) 52 +/- 10%] with standard indication for dual-chamber pacing. Patients were evaluated at rest in the supine position. The AV delay was set at 130 ms, and the pacing rate was increased from 90 to 130 bpm (10 bpm steps for 3 min). At the end of each 3 min step, QT intervals were automatically evaluated in real time by means of pacemaker telemetry. We also evaluated heart performance by means of echo-2D (end-diastolic/end-systolic volumes, EF) and echo-Doppler measurements [left ventricular ejection time (LVET) and diastolic filling time (LVDFT), aortic velocity time integral, and systolic volume] and systemic arterial pressure. The QT interval progressively decreased from 330 +/- 20 to 280 +/- 10 ms as the pacing rate was increased from 90 to 130 bpm. The correlation between the QT interval and LVET as a function of the pacing rate was R(2) = 0.966, indicating a good and relatively parallel trend in these two parameters. The correlation between RR-QT (reflecting electrical diastole) and LVDFT (reflecting mechanical diastole) was R(2) = 0.975. The index LVET/QT (ratio between mechanical and electrical systole) was constant in the range 90-120 bpm, but significantly decreased at 130 bpm: the mechanical LVET shortens more than the electrical QT does at the highest heart rates. CONCLUSION In paced patients at rest and during artificially increased heart rates, QT interval dynamics is closely correlated with changes in ejection time, thus constituting an electrical parameter of systolic time. A similar correlation exists between RR-QT, as a diastolic electrical interval, and the DFT.

Inappropriate Asystole Detection in Early Postoperative Phase after Loop Recorder Implantation

The implantable loop recorder is a useful diagnostic tool for patients with unexplained syncope. The capability to automatically detect and store arrhythmic events, implemented in the last generations of these devices, can further improve the diagnostic yield, but this feature can be compromised by inappropriate detection of false arrhythmias. We herein report the case of a patient in which several inappropriate activations of long-lasting asystole occurred in the two days following the implant, probably because of an intermittently loose contact between the device and subcutaneous tissue for a small pocket haematoma.

Hemodynamic Sensors: Their Impact in Clinical Practice

The need to adjust pacing rate to changing metabolic conditions has led to the development of different sensing systems that integrate the detection of atrial and ventricular electrical signals in permanent pacemakers [1]. All sensors currently available in the clinical setting assess the patient’s metabolic demand indirectly. This is the case for activity sensors, which generally detect the intensity of body motion by an accelerometer, as well as for physiological sensors, which are sensitive to cardiac or respiratory parameters physiologically correlated to the cardiac rate. The activity sensors usually show good sensitivity and prompt rate-response, but may lack specificity, since they cannot distinguish between active and passive motion. Respiratory sensors are more specific, but they show a slow response, resulting in little sensitivity towards the rapid, small changes in a patient’s activity which normally occur in daily life [2]. Cardiac sensors have to present the best compromise between sentivity and speciaficity, since the different aspects of cardiac function are regulated at the same time by the same controller, the autonomic nervous system (ANS). In patients with chronotropic incompetence, a pacemaker would restore normal rate control on the basis of relative changes in the inotropic, dromotropic, or bathmotropic regulation of the heart [3].

Can Hemodynamic Sensors Ensure Physiological Rate Control

Hemodynamic sensors are used mainly in clinical pacing to assess the inotropic state of the heart, with the aim of matching the pacing rate to the contractility level. If the patient’s chronotropic competence is depressed, this approach should allow proper cardiac rate regulation based on the physiological correlation between inotropic and chronotropic function [1–4].

Prevalence of ventricular arrhythmias in patients with cardiac resynchronization therapy without back-up ICD: a single-center experience.

Aims Current guidelines recommend cardiac resynchronization therapy (CRT) in selected heart failure patients, but do not precisely clarify when a back-up implantable cardioverter defibrillator (ICD) should be associated (CRT-D). In this study we evaluate the occurrence of ventricular arrhythmias in a population of patients implanted with biventricular pacemaker without a back-up ICD (CRT-P). Methods We performed a retrospective analysis on 84 patients (55 men, mean age 74 ± 7 years), implanted with a CRT-P since April 2000. Patients had in 31% an underlying coronary artery disease, in 56% an idiopatic dilated cardiomyopathy and in 13% a valvular disease. An upgrade to CRT-P was performed from previous conventional pacemakers in 36% of cases. Baseline New York Heart Association (NYHA) functional class was II in 25%, III in 63% and IV in 12%. Mean left ventricular ejection fraction was 29.8 ± 8.8% with two-dimensional echo. During follow-up, occurrence of ventricular arrhythmias was assessed clinically and through the pacemaker stored data at the scheduled check-up. Results During a mean follow-up of 29 months (range 2–127 months), telemetry interrogation revealed unsustained ventricular tachyarrhythmias in 11 of 84 patients (13.1%). Only one patient experienced an episode of sustained ventricular tachycardia. An upgrading to a CRT-D was performed in two patients; one of these patients died suddenly 15 months after the upgrade. Death occurred in 20 of 84 patients (23.8%): 15 for refractory heart failure and five for noncardiac causes. Conclusion Our data show that CRT-P may be well tolerated in selected patients even during a long-term follow-up; and that an upgrade to CRT-D may not be enough to prevent sudden death.